IOLYX THERAPEUTICS Trademark

Trademark Overview


On Friday, December 26, 2025, a trademark application was filed for IOLYX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the IOLYX THERAPEUTICS trademark a serial number of 99566643. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, April 27, 2026. This trademark is owned by Iolyx Therapeutics, Inc.. The IOLYX THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of ophthalmological, immunological, and inflammatory diseases and disorders

Pharmaceutical research and development; Medical and scientific research in the field of in the field of pharmaceutical development; Providing scientific information in the field of pharmaceutical development, namely, providing information about scientific research related to development of pharmaceuticals; Medical and scientific research information in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals
iolyx therapeutics

General Information


Serial Number99566643
Word MarkIOLYX THERAPEUTICS
Filing DateFriday, December 26, 2025
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateMonday, April 27, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of ophthalmological, immunological, and inflammatory diseases and disorders
Goods and ServicesPharmaceutical research and development; Medical and scientific research in the field of in the field of pharmaceutical development; Providing scientific information in the field of pharmaceutical development, namely, providing information about scientific research related to development of pharmaceuticals; Medical and scientific research information in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals
Description of MarkThe mark consists of the stacked literal elements IOLYX THERAPEUTICS to the right of the design of an abstract six pointed star with the opposite points forming almond shapes and in the center of which is a circle with a highlight crescent at the upper right of the circle, resembling an eye.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 26, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIolyx Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94010
US

Trademark Events


Event DateEvent Description
Friday, December 26, 2025NEW APPLICATION ENTERED
Friday, December 26, 2025APPLICATION FILING RECEIPT MAILED
Sunday, April 19, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, April 19, 2026NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, April 27, 2026ASSIGNED TO EXAMINER